Main View
This view is used for searching all possible sources.
First Page Previous Page 1 2 3 4 Next Page Last Page
 
1
Abbott RealTime HIV-1 Amplification Reagent Kit, Abbott RealTime ...

... Abbott RealTime HIV-1 Amplification Reagent Kit, Abbott RealTime HIV-1 Calibrator Kit, Abbott RealTime HIV-1 Control Kit. ...

Center for Biologics Evaluation and Research (CBER)

2
Letter - Abbott RealTime HIV-1 Amplification Reagent Kit ...

... Device Code: MZF. ... Upgrade the m2000 system software to add a code that will not allow the system to use expired reagents. ...

Center for Biologics Evaluation and Research (CBER)

3
BP060002/0, Abbott RealTime HIV-1 Amplification Reagent ...

... For detailed information on application file installation, refer to the ... 1 assay with the Abbott m2000 system and 1.0 ... Sebire K, McGavin K, Land S, et al ...

Center for Biologics Evaluation and Research (CBER)

4
BP060002 - Abbott RealTime HIV-1 Amplification Reagent Kit, Abbott ...

... Internal Control RNA. The reagent also contains dNTPs, ROX� passive reference dye and an aptamer oligonucleotide. The reagent is formulated in a ...

Center for Biologics Evaluation and Research (CBER)

5
Performance evaluation of the COBAS/TaqMan HIV-1 v2.0 in HIV-1 positive patients with low viral load: a comparative study.
2011-03-16

HIV-1 viral load determination is a crucial step for monitoring the efficacy of highly active antiretroviral therapy (HAART) and predicts disease progression. Real-time PCR based assays are available for monitoring the viral load. They differ in sensitivity, genomic target region and dynamic range. In this study, the performance of the ...

PubMed

6
BP060002/0, Abbott RealTime HIV-1 Amplification Reagent Kit ...

... Reliability of assay results cannot be guaranteed if there are any deviations from the instructions in this package insert. Page 2. Key to symbols used ...

Center for Biologics Evaluation and Research (CBER)

7
Comparison of the Abbott m2000 HIV-1 Real-Time and Roche AMPLICOR Monitor v1.5 HIV-1 assays on plasma specimens from Rakai, Uganda.
2011-07-01

The need for viral load (VL) monitoring of HIV patients receiving antiretroviral therapy (ART) in resource-limited settings (RLS) has become apparent with studies showing the limitations of immunological monitoring. We compared the Abbott m2000 Real-Time (Abbott) HIV-1 assay with the Roche ...

PubMed

8
HIV-1/2

... Screening; Infectious Disease Tests. -. HIV-1/2. -. Human Immunodeficiency Virus Types 1 & 2 (Anti-HIV-1/2 Assay). Abbott ...

Center for Biologics Evaluation and Research (CBER)

9
Comparative evaluation of the performance of the Abbott RealTime HIV-1 assay for measurement of HIV-1 plasma viral load on genetically diverse samples from Greece
2011-01-11

BackgroundHIV-1 is characterized by increased genetic heterogeneity which tends to hinder the reliability of detection and accuracy of HIV-1 RNA quantitation assays.MethodsIn this study, the Abbott RealTime HIV-1 (Abbott RealTime) ...

PubMed Central

10
Evaluation of effect of specimen-handling parameters for plasma preparation tubes on viral load measurements obtained by using the Abbott RealTime HIV-1 load assay.
2010-05-19

HIV-1 viral load testing is essential to the management of HIV-1-infected patients, and proper specimen handling ensures accurate viral load (VL) results. This study was performed to (i) evaluate the effect of freezing plasma in situ in BD Vacutainer plasma preparation tubes (PPT) on the accuracy of HIV-1 viral load results using the ...

PubMed

11
High correlation between the Roche COBAS(�) AmpliPrep/COBAS(�) TaqMan(�) HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
2011-08-01

BACKGROUND: HIV-1 viral load assays are critical tools to monitor antiretroviral therapy efficacy in HIV-infected patients. Two assays based on real-time PCR are available, the Abbott Real-Time HIV-1 assay (Abbott assay) and the new ...

PubMed

12
ABBOTT HIVAB HIV-1/HIV-2 (rDNA) EIA

HIVAB HIV-1/HIV-2 (rDNA) EIA is an in vitro enzyme immunoassay for the qualitative detection of antibodies to human immunodeficiency viruses ...

Center for Biologics Evaluation and Research (CBER)

13
Development of candidate reference reagent for HIV-1 RNA and comparison analysis for different HIV-1 RNA quantitative assay.
2011-06-10

Abstract Background: Human immunodeficiency virus type-1 (HIV-1) RNA viral load is a surrogate marker that is routinely used to determine indications for, and monitor the effectiveness of HIV-1 treatment. We developed three reagents for potential use in routine quality control of HIV-1 RNA quantitative assays. In this report, we compare the stability of ...

PubMed

14
A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region.
2007-02-26

Given the worldwide increasing spread of HIV-1 genetic variants, it is mandatory that assays used for nucleic acid testing for HIV-1 detect all existing groups and subtypes of HIV-1. In this report the development and evaluation of a quantitative real-time HIV-1 RT-PCR assay that targets a conserved region within the pol integrase ...

PubMed

15
Recall of Abbott Prism HIV O Plus

... REASON: Abbott has seen an increase in customer complaints for calibration failures when PRISM-HIV-1 Group O Positive Assay Control (2) (Symbol: OPC) is out of ...

Center for Biologics Evaluation and Research (CBER)

16
Comparison of the Abbott RealTime Human Immunodeficiency Virus Type 1 (HIV-1) Assay to the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test: Workflow, Reliability, and Direct Costs?
2009-04-04

The Abbott RealTime human immunodeficiency virus type 1 (HIV-1) assay (ART) and the Cobas AmpliPrep/Cobas TaqMan HIV-1 test (CTM) are commercially available assays for quantification of HIV-1 RNA in plasma. We evaluated performance characteristics, workflow, throughput, ...

PubMed Central

17
Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA.
2011-05-28

Abstract Background: Diagnostic laboratories need automation that facilitates efficient processing and workflow management to meet today's challenges for expanding services and reducing cost, yet maintaining the highest levels of quality. Methods: Processing efficiency of two commercially available automated systems for quantifying HIV-1 and HCV RNA, ...

PubMed

18
ABBOTT PRISM HIV O Plus

... For the detection of antibodies to HIV-1 (anti-HIV-1) Groups M and O and/or antibodies to HIV-2 (anti-HIV-2) in human serum and plasma ...

Center for Biologics Evaluation and Research (CBER)

19
Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for Determination of HIV-1 Viral Loads in a Cohort of Canadian Patients with Diverse HIV Subtype Infections?
2011-01-17

HIV clinics in Canada provide care to an increasing number of patients born outside of Canada with HIV-1 non-B subtype infections. Because the Easy Q HIV-1 v1.2 assay (EQ; bioM�rieux) failed to detect some non-B subtype infections, a multiassay HIV-1 viral load (VL) study was conducted with patients with diverse ...

PubMed Central

20
Correlation between human immunodeficiency virus type 1 (HIV-1) RNA measurements obtained with dried blood spots and those obtained with plasma by use of Nuclisens EasyQ HIV-1 and Abbott RealTime HIV load tests.
2009-02-04

The plasma human immunodeficiency virus (HIV) RNA load is used in the clinical routine for the monitoring of HIV infection and the patient's response to antiretroviral therapy. Other body fluids or dried blood spots (DBS) can be used, however, to assess the level of viremia. The use of DBS may be especially helpful for the monitoring of HIV-infected patients in resource-poor settings, where access ...

PubMed

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
21
171 - NASA Technical Reports Server

Mar 1, 2011 ... Using a real-time quantitative polymerase chain reaction assay, we demonstrated that significantly more HIV-1-infected patients receiving ...

NASA Website

22
157 - NASA Technical Reports Server

Mar 1, 2011 ... Using a real-time quantitative polymerase chain reaction assay, we demonstrated that significantly more HIV-1-infected patients receiving ...

NASA Website

23
Adenovirus Vectors Block Human Immunodeficiency Virus�1 Replication in Human Alveolar Macrophages by Inhibition of the Long Terminal Repeat
2010-08-05

Heterologous viruses may transactivate or suppress human immunodeficiency virus (HIV)�1 replication. An adenovirus type 5 gene transfer vector (Ad5) HIV-1 vaccine was recently evaluated in a clinical trial, without efficacy. In this context, it is relevant to ask what effect Ad vectors have on HIV-1 replication, ...

PubMed Central

24
A New Approach to Real-Time Transaction Scheduling
2011-05-14

... Abbott and Garcia-Molina [Abb88] described a group of lock-based real-time concurrency control schemes for scheduling soft real-time transactions ...

DTIC Science & Technology

25
Using Dynamic Adjustment of Serialization Order for Real ...
2011-05-14

... Abbott, R. and H. Garcia-Molina, �Scheduling Real-Time Transactions: A Performance Evaluation,� Proceedings of the 14th VLDB Conference, Aug. ...

DTIC Science & Technology

26
Evaluation of the Abbott RealTime HBV DNA assay and comparison to the Cobas AmpliPrep/Cobas TaqMan 48 assay in monitoring patients with chronic cases of hepatitis B.
2008-02-13

The new Abbott RealTime hepatitis B virus (HBV) assay was compared to the Cobas AmpliPrep/Cobas TaqMan assay with 128 serum samples from patients with chronic hepatitis B. There was an excellent correlation (r = 0.961) between the two assays, with the Abbott RealTime test showing at least equivalent sensitivity and ...

PubMed

27
Evaluation of the Abbott RealTime HBV DNA Assay and Comparison to the Cobas AmpliPrep/Cobas TaqMan 48 Assay in Monitoring Patients with Chronic Cases of Hepatitis B?
2008-04-13

The new Abbott RealTime hepatitis B virus (HBV) assay was compared to the Cobas AmpliPrep/Cobas TaqMan assay with 128 serum samples from patients with chronic hepatitis B. There was an excellent correlation (r = 0.961) between the two assays, with the Abbott RealTime test showing at least equivalent sensitivity and ...

PubMed Central

28
DRDB: A Distributed Real-Time Database Server for High ...
2011-05-14

... R.Abbott, and H.Garcia-Molina, �Scheduling Real-time Transactions: a Performance Eval- uation,'' ACM Trans. on Database Systems, vol. 17, no. ...

DTIC Science & Technology

29
Evaluation of the QIAsymphony� SP and Artus� RealTime extraction-quantification systems for measuring HIV-1 virus load.
2011-09-22

BACKGROUND: Automated HIV-1 RNA extraction and its quantification by real-time PCR assays provide improved sample processing and better analytical performances. The new Artus HIV-1 RealTime assay can be performed after automated extraction with the Qiagen Qiasymphony robot. ...

PubMed

30
Early HIV-1 diagnosis using in-house real time PCR amplification on dried blood spots for infants in remote and resource limited settings
2008-12-15

BackgroundIn resource-limited settings, most perinatally HIV-1-infected infants do not receive timely antiretroviral therapy because early HIV-1 diagnosis is not available or affordable.ObjectiveTo assess the performance of a low cost in-house real-time PCR assay to detect ...

PubMed Central

31
Reappearance of Minority K103N HIV-1 Variants after Interruption of ART Initiated during Primary HIV-1 Infection
2011-07-06

BackgroundIn the Zurich Primary HIV infection study (ZPHI), minority drug-resistant HIV-1 variants were detected in some acutely HIV-1-infected patients prior to initiation of early antiretroviral therapy (ART). Here, we investigated the reappearance of minority K103N and M184V ...

PubMed Central

32
The measurement of HIV-1 viral load in resource-limited settings: how and where?
2007-01-01

There is an urgent need for low-cost, simple, and accurate human immunodeficiency virus type 1 (HIV-1) viral load monitoring technologies in resource-limited settings, particularly at the time of the scaling-up of first and second-line highly active antiretroviral therapies. This review describes the main characteristics and advantages/ disadvantages of ...

PubMed

33
Lack of Detection of XMRV in Seminal Plasma from HIV-1 Infected Men in The Netherlands
2010-08-10

BackgroundXenotropic murine leukaemia virus-related virus (XMRV) is a recently discovered human gammaretrovirus with yet unknown prevalence and transmission route(s). Its presence in prostate stromal fibroblasts and prostatic secretions suggests that XMRV might be sexually transmitted. We chose to study a compartment closely connected to the prostate, a location where XMRV was detected in ...

PubMed Central

34
APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells
2008-05-25

Cellular APOBEC3G (A3G) protein is packaged into human immunodeficiency virus type 1 (HIV-1) virions in producer cells yet restricts viral replication in target cells. To characterize this restriction in target cells, the effect of A3G on generating various HIV-1 cDNA products was measured by quantitative ...

Energy Citations Database

35
Quantitative PCR used to Assess HIV-1 Integration and 2-LTR Circle Formation in Human Macrophages, Peripheral Blood Lymphocytes and a CD4+ Cell Line
2010-12-03

BackgroundIntegration is an intermediate step in the HIV life cycle and is defined as the insertion of HIV-1 proviral DNA into the host chromosome. If integration does not occur when HIV-1 cDNA enters the nucleus, it circularizes upon itself and forms a 2-LTR circle. Monitoring the level of integrated HIV-1 cDNA in ...

PubMed Central

36
Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe
2010-06-08

BackgroundHIV-1 genotypic drug resistance is an important threat to the success of antiretroviral therapy and transmitted resistance has reached 9% prevalence in Europe. Studies have demonstrated that HIV-1 DNA load in peripheral blood mononuclear cells (PBMC) have a predictive value for disease progression, independently of CD4 counts and plasma viral ...

PubMed Central

37
Performance of a Rapid and Simple HIV Testing Algorithm in a Multicenter Phase III Microbicide Clinical Trial.
2011-07-13

A multi-test sequential algorithm based on Rapid/Simple (R/S) assays was applied for the diagnosis of HIV infection among participants in a phase 3 microbicide effectiveness trial. HIV testing was performed on finger-prick blood samples from patients after their enrollment in the trial. The specimens were tested in a serial procedure using three different rapid tests (Determine ...

PubMed

38
Modulation of the proteome of peripheral blood mononuclear cells from HIV-1 infected patients by drugs of abuse
2009-06-20

We used proteomic analyses to assess how drug abuse modulates immunologic responses to infections with the human immunodeficiency virus type 1 (HIV-1). Two dimensional (2D) difference gel electrophoresis was utilized to determine changes in the proteome of peripheral blood mononuclear cells (PBMC) isolated from ...

PubMed Central

39
Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin {alpha} interactions as a novel HIV-1 therapy
2009-03-20

The development of multidrug-resistant viruses compromises the efficacy of anti-human immunodeficiency virus (HIV) therapy and limits treatment options. Therefore, new targets that can be used to develop novel antiviral agents need to be identified. One such target is the interaction between Vpr, one of the accessory gene products of HIV-1 and Importin {alpha}, which is crucial, not only for the ...

Energy Citations Database

40
HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 coinfected men who have sex with men (MSM)
2009-02-20

ObjectivesSuppressive HSV therapy can decrease plasma, cervical, and rectal HIV-1 levels in HSV-2/HIV-1 co-infected persons. We evaluated the effect of HSV-2 suppression on seminal HIV-1 levels.DesignTwenty antiretroviral therapy (ART)�naive HIV-1/HSV-2�MSM in Lima, ...

PubMed Central

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
41
Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: impact on HBV genotype monitoring.
2008-11-04

The quantitation of human hepatitis B virus (HBV) in the serum of infected patients is recommended to characterize the course of chronic HBV infection. The aim of this prospective study was to evaluate the performance of the Abbott RealTime PCR assay for HBV DNA quantitation by comparison with the standard Versant HBV DNA 3.0 assay. The better sensitivity ...

PubMed

42
Effect of topical microbicides on infectious human immunodeficiency virus type 1 binding to epithelial cells.
2007-04-02

Topical microbicides (cellulose acetate 1,2 benzene dicarboxylate [CAP], PRO 2000, SPL7013, and UC781) are being investigated to reduce the sexual transmission of human immunodeficiency virus type 1 (HIV-1). These products were shown to prevent the transfer of infectious HIV-1 from urogenital and colorectal ...

PubMed

43
Effect of Topical Microbicides on Infectious Human Immunodeficiency Virus Type 1 Binding to Epithelial Cells?
2007-06-02

Topical microbicides (cellulose acetate 1,2 benzene dicarboxylate [CAP], PRO 2000, SPL7013, and UC781) are being investigated to reduce the sexual transmission of human immunodeficiency virus type 1 (HIV-1). These products were shown to prevent the transfer of infectious HIV-1 from urogenital and colorectal ...

PubMed Central

44
Quantitation of HIV-1 group M proviral DNA using TaqMan MGB real-time PCR.
2009-03-10

The level of human immunodeficiency virus type 1 (HIV-1) proviral DNA is likely to be an important marker of the long-term effectiveness of highly active antiretroviral therapy. A new method was developed for quantifying HIV-1 group M proviral DNA using TaqMan real-time PCR, in which degenerate ...

PubMed

45
Low Prevalence Rate of Indeterminate Serological Human Immunodeficiency Virus Results among Pregnant Women from Burkina Faso, West Africa?
2010-04-03

Rapid human immunodeficiency virus (HIV) antibody tests have been adopted into national guidelines for HIV testing in many countries in sub-Saharan Africa. One goal of HIV rapid testing is to minimize the occurrence of indeterminate results. From January 2005 to December 2007, plasma (or serum) samples from pregnant women in Bobo-Dioulasso (Burkina Faso, West Africa) were screened for HIV by using ...

PubMed Central

46
CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs
2011-05-13

BackgroundTransmission of human immunodeficiency virus type 1 (HIV-1) through breast-feeding may involve both cell-free and cell-associated virus. This latter viral reservoir remains, however, to be fully explored. CD4+ T cell-associated virus production in breast milk was therefore investigated.MethodsThe ex vivo spontaneous ...

PubMed Central

47
Low-Cost HIV-1 Diagnosis and Quantification in Dried Blood Spots by Real Time PCR
2009-06-05

BackgroundRapid and cost-effective methods for HIV-1 diagnosis and viral load monitoring would greatly enhance the clinical management of HIV-1 infected adults and children in limited-resource settings. Recent recommendations to treat perinatally infected infants within the first year of life are feasible only if early diagnosis is routinely available. Dried blood spots (DBS) on filter paper are ...

PubMed Central

48
Performance characteristics and comparison of Abbott and artus real-time system for hepatitis B virus DNA quantification.
2011-07-27

Virological monitoring of hepatitis B virus (HBV) DNA is critical to the management of HBV infection. With several HBV DNA quantification assays available, it is important to use the most efficient testing system for virological monitoring. In this study we evaluated the performance characteristics and comparability of three HBV DNA quantification systems: Abbott HBV ...

PubMed

49
Characterization of a New Sensitive PCR Assay for Quantification of Viral DNA Isolated from Patients with Hepatitis B Virus Infections?
2007-12-17

Sensitive and accurate quantification of hepatitis B virus (HBV) DNA is necessary for monitoring patients with chronic hepatitis receiving antiviral therapy in order to determine treatment response and to adapt therapy in case of inadequate virologic control. The development of quantitative PCR assays has been crucial in meeting these needs. The objective of this study was to compare the ...

PubMed Central

50
Comparison of clinical performance of Abbott RealTime High Risk HPV test with that of hybrid capture 2 assay in a screening setting.
2011-02-16

Randomized trials have produced sound evidence about the efficacy of screening with human papillomavirus (HPV) DNA tests in reducing cervical cancer incidence and mortality. We evaluated the clinical performance and reproducibility of the Abbott RealTime High Risk (HR) HPV test compared with that of the HR hybrid capture 2 (HC2) assay as assessed by a ...

PubMed

51
Improving HIV-2 Detection by a Combination of Serological and Nucleic Acid Amplification Test Assays?
2010-08-23

The ability to detect HIV-2 and to discriminate between HIV-1 and HIV-2 infections was evaluated in 46 serum samples from Guinea-Bissau (GB) and Guinea-Conakry (GC) using serological tests and commercial (HIV-1) and in-house (HIV-2) real-time PCR assays. Samples were first identified as HIV-2 ...

PubMed Central

52
An optimized sensitive method for quantitation of DNA/RNA viruses in heparinized and cyropreserved plasma.
2011-05-17

Sodium heparin, an anticoagulant used widely for blood collection, has been known to inhibit DNA polymerase activity in polymerase chain reaction (PCR) assays. However, all cryopreserved plasma samples collected in the 1980s and early 1990s at the Multicenter AIDS Cohort Study were from heparin-treated blood, which poses a problem in quantifying the target nucleic acids contained in those samples ...

PubMed

53
Compartmentalization of the gut viral reservoir in HIV-1 infected patients
2007-12-04

BackgroundRecently there has been an increasing interest and appreciation for the gut as both a viral reservoir as well as an important host-pathogen interface in human immunodefiency virus type 1 (HIV-1) infection. The gut associated lymphoid tissue (GALT) is the largest lymphoid organ infected by HIV-1. In this study we examined if different ...

PubMed Central

54
Molecular detection and confirmation of Neisseria gonorrhoeae in urogenital and extragenital specimens using the Abbott CT/NG RealTime assay and an in-house assay targeting the porA pseudogene.
2010-12-19

Culture for detection of Neisseria gonorrhoeae (NG) is being replaced by molecular assays, but difficulties are observed with false positive and negatives results, especially for extragenital samples. This study evaluates the Abbott CT/NG Real-Time assay and a real-time porA pseudogene assay. Samples (n = 600) from a mixed prevalence ...

PubMed

55
Evaluation of the Abbott RealTime CT/NG assay in comparison to the Roche Cobas Amplicor CT/NG assay.
2011-02-16

Several commercial methods exist for the molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeae in clinical samples. Here we evaluated the performance characteristics of the newly FDA-cleared Abbott RealTime CT/NG assay (where "CT" stands for Chlamydia trachomatis and "NG" stands for Neisseria gonorrhoeae) that uses the automated m2000 ...

PubMed

56
Use of Fluorognost HIV-1 Immunofluorescent Assay (IFA)

Page 1. Use of Fluorognost HIV-1 Immunofluorescent Assay (IFA) (4/23/92) ... SUBJECT: Use of Fluorognost HIV-1 Immunofluorescent Assay (IFA) ...

Center for Biologics Evaluation and Research (CBER)

57
Roche Amplicor HIV-1 Monitor Test

... Roche Amplicor HIV-1 Monitor Test. ... Product Information. Label - Roche Amplicor HIV-1 Monitor Test (PDF - 3536KB). -. -. Supporting Documents. ...

Center for Biologics Evaluation and Research (CBER)

58
Home Access HIV-1 Test System

... Premarket Approvals with Supporting Documents. -. Home Access HIV-1 Test System. ... Product Information. Label - Home Access HIV-1 Test System (PDF - 2243KB). -. -. ...

Center for Biologics Evaluation and Research (CBER)

59
HIV-1 (Western Blot)

... Science & Research (Biologics); News & Events (Biologics); Resources for You (Biologics). -. HIV-1 (Western Blot). ... HIV-1 (Western Blot). ...

Center for Biologics Evaluation and Research (CBER)

60
APTIMA HIV-1 RNA Qualitative Assay

... APTIMA HIV-1 RNA Qualitative Assay. ... Product Information. APTIMA HIV-1 RNA Qualitative Assay Package Insert (PDF - 608KB). -. -. Supporting Documents. ...

Center for Biologics Evaluation and Research (CBER)

First Page Previous Page 1 2 3 4 Next Page Last Page
 
First Page Previous Page 1 2 3 4 Next Page Last Page
 
61
HIV-1 drug resistance testing from dried blood spots collected in rural Tanzania using the ViroSeq HIV-1 Genotyping System
2011-02-25

ObjectivesTo assess whether the commercial ViroSeq HIV-1 Genotyping System (Abbott Molecular, Des Plains, IL, USA) can be used in conjunction with dried blood spots (DBS) for clinical monitoring of drug resistance in patients who fail antiretroviral treatment (ART) in rural Tanzania.Patients and methodsPatients at Haydom Lutheran ...

PubMed Central

62
Industrial Advisory Board
2011-06-23

'95-'96 Roger Gordon Industrial Advisory Board Abbott Laboratories Dr. Jonathan Miller Principal Scientist Abbott Laboratories 200 Abbott Park Road Abbott Park, IL 60064...

Science.gov Websites

First Page Previous Page 1 2 3 4 Next Page Last Page